P
Paulo Roque Obreli-Neto
Researcher at Universidade Estadual de Maringá
Publications - 23
Citations - 437
Paulo Roque Obreli-Neto is an academic researcher from Universidade Estadual de Maringá. The author has contributed to research in topics: Internal medicine & Randomized controlled trial. The author has an hindex of 8, co-authored 20 publications receiving 370 citations. Previous affiliations of Paulo Roque Obreli-Neto include University of São Paulo.
Papers
More filters
Journal ArticleDOI
Adverse drug reactions caused by drug–drug interactions in elderly outpatients: a prospective cohort study
Paulo Roque Obreli-Neto,Alessandro Nobili,André Oliveira Baldoni,Camilo Molino Guidoni,Divaldo Pereira de Lyra Júnior,Diogo André Pilger,Juliano Duzanski,Mauro Tettamanti,Joice Mara Cruciol-Souza,Walderez Penteado Gaeti,Roberto Kenji Nakamura Cuman +10 more
TL;DR: The incidence of DDI-related ADRs in elderly outpatients is high; most events presented important clinical consequences and were preventable or ameliorable.
Journal ArticleDOI
Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients.
Paulo Roque Obreli-Neto,Camilo Molino Guidoni,André Oliveira Baldoni,Diogo André Pilger,Joice Mara Cruciol-Souza,Walderez Penteado Gaeti-Franco,Roberto Kenji Nakamura Cuman +6 more
TL;DR: The effectiveness of pharmaceutical care in improving pharmacotherapy adherence in elderly diabetic and hypertensive patients is indicated, with positive effects in the clinical outcomes of the patients studied.
Journal ArticleDOI
Economic Evaluation of a Pharmaceutical Care Program for Elderly Diabetic and Hypertensive Patients in Primary Health Care: A 36-Month Randomized Controlled Clinical Trial
Paulo Roque Obreli-Neto,Srecko Marusic,Camilo Molino Guidoni,André Oliveira Baldoni,Rogério Dias Renovato,Diogo André Pilger,Roberto Kenji Nakamura Cuman,Leonardo Régis Leira Pereira +7 more
TL;DR: While pharmaceutical care did not significantly increase total direct health care costs, significantly improved health outcomes were seen and the mean ICER per QALY gained suggests a favorable cost-effectiveness.
Journal ArticleDOI
Incidence and Predictors of Adverse Drug Reactions Caused by Drug-Drug Interactions in Elderly Outpatients: A Prospective Cohort Study
Paulo Roque Obreli-Neto,Alessandro Nobili,Divaldo Pereira de Lyra Júnior,Diogo André Pilger,Camilo Molino Guidoni,André Oliveira Baldoni,Joice Mara Cruciol-Souza,Ana Luiza de Carvalho Freitas,Mauro Tettamanti,Walderez Penteado Gaeti,Roberto Kenji Nakamura Cuman +10 more
TL;DR: The incidence of DDI-related ADRs in elderly outpatients was significant, and most of the events presented important clinical consequences.
Journal ArticleDOI
Use of Simulated Patients to Evaluate Combined Oral Contraceptive Dispensing Practices of Community Pharmacists
Paulo Roque Obreli-Neto,Leonardo Régis Leira Pereira,Camilo Molino Guidoni,André Oliveira Baldoni,Srecko Marusic,Divaldo Pereira de Lyra-Junior,Kelsen Luis de Almeida,Ana Claudia Montolezi Pazete,Janaina Dutra do Nascimento,Mitja Kos,Edmarlon Girotto,Roberto Kenji Nakamura Cuman +11 more
TL;DR: The CPs evaluated did not dispense COC appropriately and could influence in the occurrence of negatives therapeutic outcomes such as adverse effects and treatment failure.